Arrhythmia risk of antiemetic agents [10]

Anesthesiology

Volumn 97, Issue 1, 2002, Pages 286-

  Kantor, Gareth S ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; DOLASETRON MESILATE; DROPERIDOL; ONDANSETRON;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DOSE RESPONSE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LETTER; PERIOPERATIVE PERIOD; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR; TORSADE DES POINTES;

EID: 0036305963     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200207000-00058     Document Type: Letter

References (7)

1. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes
2. Cardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramide
3. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current
4. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels
5. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: A meta-analysis